5. Uluslararası Moleküler Tıp Kongresi

Dear Colleagues,

The 5th International Congress of Molecular Medicine scheduled to be held in Elazig, Turkey on 27th-30th June 2013 has been postponed to a later date (Year 2014) upon the decision of the Organizing Committee.

We apologize in this note, for the unexpected development and we appreciate your kind understanding and effort.

The new date of the 5th International Congress of Molecular Medicine will be published as soon as possible (also participants which have contacted Organizing Secretariat shall be contacted by e-mail).

Dear Colleagues,

We are delighted to invite you to the 5th International Congress of Molecular Medicine that will be held in Elazig, Turkey, from June 27th to 30th, 2013 under the auspices of the Turkish Society of Molecular Medicine
Congress program will consist of outstanding lectures, including keynote talks, plenary sessions, oral & poster presentations & exhibition.
Submitted research abstracts will be published at “IN VIVO” (International Journal of Experimental and Clinical Pathophysiology and Drug Research).

The biennial congress of molecular medicine has been established as an important forum for researchers and clinicians from all around the world to focus on the latest developments in Molecular medicine.

It brings together intentionally recognized scientists to discuss trends, technologies and clinical applications in areas including new approaches in Genomic analyses, Molecular basis of cancer, Molecular Markers in Cancer, Free radicals in Cancer, Environment and genetics factors in lipid related disorders, Molecular mechanism of heart preconditioning, Angiogenesis, Stem cell and stem cell therapy, Genetic immunology, Proteomics and small molecules, Response therapy and molecular genetics in various disorders in field of pediatric endocrinology, Biochemistry and biochemical genetic, etc.

The venue of the congress will be the Firat (Euphrates) University – one of the biggest academic institutions in the East of Turkey. The university enjoys a high prestige at national and international level with 12 faculties, 4 institutes, 2 highschools, 1 state conservatory and 6 vocational highschools and over 20.170 students, 1.470 academicians and 1.130 administrative staff.

Elazıg, city in eastern Turkey, is situated on an elevation of 1.067 metres above sea level, near the Keban Dam, a large reservoir for the Euphrates and is surrounded by wine gardens. Elazığ was established at the foot of the historical Harput Castle, in Eastern Anatolia. According to the available historical sources, the oldest inhabitants of Harput is Hurrians in BC 2000.

The main product of Elazig and its surrounding region is wine, but a wide variety of other agricultural products are cultivated here as well. Modern Elazig is also a trading centre for crops and livestock.

In addition to the rich scientific program, rich social programs – tours will be planned for the evenings or before and after the conference. Therefore this is an excellent occasion to enjoy rich scientific program and explore Turkey and Eastern Anatolian region at the same time.

We look forward to meeting you in Elazığ on June 2013 on for this outstanding congress.

Cordially yours,
Prof. Dr. Turgay İsbir
Honorary President
Yeditepe University, Faculty of Medicine,
Chair of Department of Medical Biology & Molecular Medicine, Istanbul, Turkey

Prof. Dr. Necip İlhan
Congress President
Firat University, Faculty of Medicine,

Department of Biochemistry, Elazig, Turkey


Honorary President
Turgay İsbir

Congress President
Necip İlhan

Board of “Turkish Society of Molecular Medicine”

Fehmi Narter

Vice President
Ümit Zeybek

General Secretary
İlhan Yaylın

Financial Affairs
Kerem Özyavuz

Board Member
Necip İlhan

International Scientific Steering Committee
Aldo Tomasi
Angelo Azzi
Arzu Ergen
Bedia Ağaçhan
Franz Theuring
Hülya Yılmaz Aydoğan
İlhan Yaylım Eraltan
John G. Delinassios
Oğuz Öztürk
Peter Butterworth
Robert Mahley
Shant Kumar
Uzay Görmüş
Ümit Zeybek

Congress Secretariat
Nevin İlhan

Congress Assistant Secretariat
Bahar Toptaş
Canan Cacına
Dilara Kaman
Hande Topçu
Özlem Küçükhüseyin
Özlem Timirci Kahraman
Seda Güleç Yılmaz

Organizing Committee
Adile Muz
Altay Burak Dalan
Arzu Kaya
Asuman Sunguroğlu
Dilara Kaman
Kadirhan Sunguroğlu
Mehmet İsbir
Nevin İlhan
Saadet Gümüşlü
Teyfik Turgut

Scientific Committee
Adile Muz
Ahmet Belce
Almed El- Sohemy
Ayşen Yarat
Azmi Telefoncu
Cihat Küçükhüseyin
Erkur Attar
Feyza Darendeliler
Gülseren Bağcı
Güzide Yücebilgiç
Hatice Paşaoğlu
Hüseyin Bağcı
Hüseyin Sönmez
Hüveyda Başağa
Kemal Altaş
Mehmet Güven
Nejat Akar
Nesrin Emekli
Osman Hayran
Özcan Erel
Selim isbir
Serap İnal
Seyhan Tükel
Turgut Ulutin

General Information
27th – 30th of June 2013

Fırat University Campus, 23200, Elazığ, Turkey (The congress center is located approximately 4 km to Elazig city center, 12 km to Elazig Airport).
Website of the University: http://www.firat.edu.tr/

The official language of the congress is English.

You can follow up the latest information on scientific program, registration and accommodation from the congress website

Participation certificates shall be delivered from the registration desk during the congress.

The registration desk will be open every day between 08:00 – 20:00 during the entire conference. The unregistered participants will be able to register from the registration desk at the congress venue.

Please check “AbstractS” for more information.

Only persons with congress badges are allowed to attend the sessions. We kindly ask all participants to wear their name badges for security when entering the congress centre, during scientific sessions, exhibition and during social program.

Congress bags will be distributed to all registered participants from the registration desk.

Invitation letters that will be requested for the congress participation in order to be delivered to institutions shall be sent to the participants.

Elâzığ has a continental climate with cold and snowy winters and hot and dry summers. The average temperature in Elazig, in June at daytime is between 20 -35 °C (Avg. rainy days: 4.2, Mean monthly sunshine hours 354)

Elazığ standard time zone is UTC/GMT + 2 hours (In Daylight Saving Time period UTC/GMT + 3 h (EEST))

Onsite payments during the congress can be made in TL or in Euro. Credit cards (Visa & Mastercard) are accepted.

Passport and visa requirements may differ according to the country of origin. Please contact your travel agent or the Turkish Consulate or Embassy in your country for further advice. Also you may visit website of Ministry of Foreign Affairs of Republic of Turkey http://www.mfa.gov.tr/visa-information-for-foreigners.en.mfa

It is possible to reach Elazig via plane, train or bus.

By plane: There are direct frequent flights from Ankara, Istanbul (Ataturk & Sabiha Gokcen airports) , Izmir & abroad (depending from the season) such as Frankfurt, Dusseldorf, Hannover, Studgart. Operating flight companies: Turkish Airlines, Anadolu Jet, Pegasus Airlines, Sunexpress, German Sky Airlines etc.

By train: Train connects Elazig directly with cities in Turkey (Ankara, Kayseri, Sivas, Malatya, Muş, Tatvan, Van, Kapıköy, Adana) & Transasia (Transasya) train connects Elazig directly with Iran (Razi, Tabriz, Tehran).

Vangölü Express connects Ankara with Elaziğ and Tatvan. You can find more information at the Turkish State Railways’ website: http://www.tcdd.gov.tr/tcdding/index.htm

By bus: Turkey has a decent bus lines network which connect Elazığ with the biggest cities of Turkey (Istanbul, Izmir, Ankara, Adana, Mersin, Bursa, Konya, Eskişehir, Balıkesir, Giresun, Trabzon, Van, Malatya etc).

Main Scientific Topics

Scientific Topics

Apoptosis & Disease
Biochemistry and Biochemical Genetics
Bioinformatics in Molecular Medicine: Recent Applications, Developments and Challenges
Cell Death & Cancer
Free Radicals and Antioxidants
Genetic Immunology
Genomic Analysis and Molecular Basis of Cancer
G-Protein-Coupled Receptors
Metabolic Syndrome
Molecular Basis of Cardiovascular Diseases
Molecular Markers in Tumor Diagnosis and Therapy
Molecular Microbiology
Personalized Genetics
Phenotype, Response to Therapy and Molecular Genetics in Various Fields of Endocrinology
Proteomics and Informatics
Public Health Genomics and Nutrigenetics
Sports & Medicine
Stem Cell and Cell Therapy


Abstract submission will start on 1st of October 2012

All of the accepted abstracts will be published in journal “ IN VIVO” ( International Journal of Experimental and Clinical Pathophysiology and Drug Research) http://iv.iiarjournals.org/

Abstracts will be accepted on the understanding that they report original unpublished works that are not under consideration for publication by another journal, and that they will not be published again in the same form.

All material submitted to IN VIVO will be subject to review, when appropriate, by two members of the Editorial Board. The Editors reserve the right to improve manuscripts on grammar and style.

The use of animals in biomedical research should be under the careful supervision of a person adequately trained in this field and at all times the animals must be treated humanely. The Guiding Principles in the Care and Use of Animals approved by the Council of the American Physiological Society must be followed.

The Editors and Publishers of IN VIVO accept no responsibility for the contents and opinions expressed by the contributors. Authors should warrantee due diligence in the creation and issuance of their work.

Each registered delegate can submit 1 abstract as presenting author. If you wish to submit more than 1 abstracts, please pay additional paper fee.

Abstract submission deadline: 15th of February 2013.

Abstracts of the participants who have not registered completely until 15th of February 2013 will not be included in the abstract book, therefore, please remember to complete registration procedure within time.

Please prepare your abstract according to abstract submission guidelines and send it to [email protected]

Please send your abstract by using only Microsoft Word (PDF or other formats are not going to be accepted).

Please choose your preferable abstract presentation style (oral or poster). However, the Committee can change the form of presentation in accordance with the scientific program or the contents of the submission.

The entire abstract, excluding heading and authors’ details, must not exceed 200 words.

Abstract language is only English.
Abstracts should be written in clear, concise English & authors are requested to carefully check the spelling.
Title of the presented work should not exceed fifteen words.

Use bold capital letters for the title.

Write abstract title with first Capital letters only (try to avoid abbreviations) – e.g. Breast Cancer and Cyclin D1 Gene Polymorphysm in Turkish Women.

State author’s name without academic titles. Write names in full with first Capital letters only – e.g. Anna Brown.

Underline name and surname of the Author who will present the paper (Presenter).”

Use superscript numbers (reduced size) after the author names for addresses.

Name and full postal address of the organization the author studies/works for must be stated – e.g. Fırat University, Faculty of Medicine, Department of Molecular Medicine, Elazıg, Turkey
The abstract must contain a summary of the study’s


Materials and Methods/Patients and Methods



If you use abbreviations, they must be defined at their first usage

Abstracts not conforming to any of requirements written above shall not be considered, irrespective of their contents.
Abstracts submitted to In Vivo may be rejected without review if:
they do not fall within the journal’s policy
they do not follow the instructions to authors
language is unclear
results are not objectively based on valid experiments
they repeat results already published by the same or other authors before the submission to In Vivo.
For submissions to be considered, at least one of a abstract’s authors must have completed the congress registration procedure.

The registration fee will be refunded in amount of 100% if the abstract has been rejected by the Congress Scientific Committee and/or “In Vivo” Editors and if therefore participant will not attend the congress.

The evaluation results shall be announced to all authors in writing until 25th of March 2013.

If you have any questions please contact us at: [email protected]

Example format for Abstracts

Presentation preference: Oral or Poster

Breast Cancer and Cyclin D1 Gene Polymorphysm in Turkish Women

Ilhan Yaylım – Eraltan1, Arzu Ergen1, Uzay Gormus1, Soykan Arıkan2, Seden Kucucuk3 , Orhan Sahin3 , Nilufer Yigit1 , Yemliha Yildiz1 , Turgay Isbir1

1Department of Molecular Medicine, Faculty of Medicine, Istanbul University, Istanbul, Turkey
2Surgery Clinic, Istanbul Research and Teaching Hospital, Istanbul, Turkey
3Department of Oncology, Faculty of Medicine, Istanbul University, Istanbul, Turkey
Background/Aim: Cyclin D1 Protein…..

Materials and Methods/Patients and Methods:





Rasim Paşa Mah. Hayrullah Efendi Sok. Şeref Apt. No: 2/3, Kadıköy, Istanbul, Turkey



[email protected]


Lütfen yorumunuzu giriniz!
lütfen isminizi buraya girin